18.05
price down icon5.50%   -0.875
 
loading
Caredx Inc stock is traded at $18.05, with a volume of 26,582. It is down -5.50% in the last 24 hours and down -28.99% over the past month. CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$18.92
Open:
$17.88
24h Volume:
26,582
Relative Volume:
0.03
Market Cap:
$977.71M
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-6.7082
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
-6.67%
1M Performance:
-28.99%
6M Performance:
-38.90%
1Y Performance:
+67.52%
1-Day Range:
Value
$17.88
$17.88
1-Week Range:
Value
$17.52
$19.16
52-Week Range:
Value
$7.42
$34.84

Caredx Inc Stock (CDNA) Company Profile

Name
Name
Caredx Inc
Name
Phone
415-287-2300
Name
Address
8000 MARINA BLVD, BRISBANE, CA
Name
Employee
650
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
CDNA's Discussions on Twitter

Compare CDNA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
CDNA
Caredx Inc
17.88 977.71M 312.78M -143.56M 1.22M -2.69
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
508.90 191.99B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
204.09 145.87B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
A
Agilent Technologies Inc
118.28 33.47B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
414.63 33.04B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
183.09 31.99B 15.41B 1.37B 2.11B 7.50

Caredx Inc Stock (CDNA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-15-25 Upgrade Wells Fargo Underweight → Equal Weight
Aug-28-24 Initiated Wells Fargo Underweight
Aug-19-24 Upgrade BTIG Research Neutral → Buy
May-13-24 Downgrade Raymond James Outperform → Mkt Perform
May-01-24 Upgrade Craig Hallum Hold → Buy
Nov-09-23 Upgrade Stephens Equal-Weight → Overweight
Aug-15-23 Upgrade Raymond James Mkt Perform → Outperform
May-11-23 Downgrade BTIG Research Buy → Neutral
Mar-07-23 Downgrade Stephens Overweight → Equal-Weight
Mar-03-23 Downgrade Craig Hallum Buy → Hold
Mar-03-23 Downgrade Raymond James Strong Buy → Mkt Perform
Apr-25-22 Initiated Stephens Overweight
Jul-20-21 Resumed BTIG Research Buy
Jun-03-21 Initiated Goldman Buy
Feb-26-21 Downgrade H.C. Wainwright Buy → Neutral
Oct-30-20 Reiterated H.C. Wainwright Buy
Oct-08-20 Reiterated H.C. Wainwright Buy
Oct-02-20 Reiterated H.C. Wainwright Buy
Aug-05-20 Reiterated H.C. Wainwright Buy
Jun-26-20 Initiated BTIG Research Buy
Jun-19-20 Reiterated H.C. Wainwright Buy
Oct-01-19 Resumed Craig Hallum Buy
May-09-19 Upgrade H.C. Wainwright Neutral → Buy
Feb-15-19 Initiated Jefferies Buy
Oct-23-18 Resumed Raymond James Strong Buy
Sep-18-18 Reiterated H.C. Wainwright Neutral
Nov-27-17 Initiated H.C. Wainwright Buy
Jun-14-16 Reiterated Mizuho Buy
Sep-29-15 Downgrade Raymond James Outperform → Mkt Perform
Sep-25-15 Initiated Craig Hallum Buy
Mar-18-15 Reiterated Mizuho Buy
View All

Caredx Inc Stock (CDNA) Latest News

pulisher
03:19 AM

CareDx, Inc (NASDAQ:CDNA) Shares Bought by US Bancorp DE - Defense World

03:19 AM
pulisher
Mar 13, 2025

CareDx: Some Litigation Clouds Have Cleared - Seeking Alpha

Mar 13, 2025
pulisher
Mar 13, 2025

CareDx director George Bickerstaff sells $367,102 in common stock - Investing.com India

Mar 13, 2025
pulisher
Mar 12, 2025

CareDx Director Makes Significant Stock Sale! - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

CareDx director George Bickerstaff sells $367,102 in common stock By Investing.com - Investing.com UK

Mar 12, 2025
pulisher
Mar 11, 2025

Why CareDx's (NASDAQ:CDNA) Earnings Are Weaker Than They Seem - Simply Wall St

Mar 11, 2025
pulisher
Mar 11, 2025

CareDx Launches Two Expanded Indications for AlloSure Testing Services - BioSpace

Mar 11, 2025
pulisher
Mar 11, 2025

Major Breakthrough: CareDx AlloSure Now Covers Infant Heart and Dual-Organ Transplant Testing - StockTitan

Mar 11, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Has $406,000 Stock Position in CareDx, Inc (NASDAQ:CDNA) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

HC Wainwright Has Negative Estimate for CareDx Q1 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

(CDNA) On The My Stocks Page - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 05, 2025

Rhumbline Advisers Boosts Stake in CareDx, Inc (NASDAQ:CDNA) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

New York State Common Retirement Fund Sells 15,584 Shares of CareDx, Inc (NASDAQ:CDNA) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

CareDx (NASDAQ:CDNA) Trading Down 7.9% Following Analyst Downgrade - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - Business Wire

Mar 04, 2025
pulisher
Mar 04, 2025

CareDx stock price target cut to $25 at H.C. Wainwright By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 04, 2025

CareDx (NASDAQ:CDNA) Price Target Cut to $25.00 by Analysts at HC Wainwright - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

CareDx stock price target cut to $25 at H.C. Wainwright - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Where CareDx Stands With Analysts - Benzinga

Mar 03, 2025
pulisher
Mar 02, 2025

CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc.CDNA - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 01, 2025

CareDx, Inc (NASDAQ:CDNA) Shares Sold by ARK Investment Management LLC - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

CareDx (NASDAQ:CDNA) Shares Gap Up Following Strong Earnings - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Decoding CareDx Inc (CDNA): A Strategic SWOT Insight - GuruFocus.com

Mar 01, 2025
pulisher
Mar 01, 2025

CareDx (NASDAQ:CDNA) Upgraded by StockNews.com to "Buy" Rating - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

CareDx, Inc (NASDAQ:CDNA) Q4 2024 Earnings Call Transcript - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Bradley & Co. Private Wealth Management LLC Invests $269,000 in CareDx, Inc (NASDAQ:CDNA) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

CareDx (NASDAQ:CDNA) Shares Gap Up After Better-Than-Expected Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Stephens Reaffirms Overweight Rating for CareDx (NASDAQ:CDNA) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

CareDx, Inc. SEC 10-K Report - TradingView

Feb 28, 2025
pulisher
Feb 27, 2025

CareDx Inc. Reports Strong Growth and Positive Outlook - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx (NASDAQ:CDNA) Issues Quarterly Earnings Results - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx: Q4 Earnings Snapshot - mySA

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx Inc (CDNA) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Caredx Inc earnings beat by $0.41, revenue topped estimates - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

CareDx Announces Fourth Quarter and Full Year 2024 Financial Results - BioSpace

Feb 27, 2025
pulisher
Feb 26, 2025

CareDx Reports Strong 2024 Financial Performance - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: CareDx Q4 2024 beats EPS forecast, stock rises By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings call transcript: CareDx Q4 2024 beats EPS forecast, stock rises - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

CareDx Reports Strong 2024 Financial Results and Growth - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings Flash (CDNA) CAREDX INC. Reports Q4 Revenue $86.6M, vs. FactSet Est of $84.1M - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Report: Developing Opportunities within VEREIT, CareDx, CymaBay Therapeutics, and HarscoFuture Expectations, Projections Moving into 2019 - ACCESS Newswire

Feb 26, 2025
pulisher
Feb 25, 2025

CareDx gets $96M jury verdict overturned in Natera patent dispute - MSN

Feb 25, 2025
pulisher
Feb 25, 2025

CareDx stock down despite court win over Natera (CDNA:NASDAQ) - Seeking Alpha

Feb 25, 2025
pulisher
Feb 25, 2025

CareDx Inc (CDNA) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Feb 25, 2025
pulisher
Feb 25, 2025

Court invalidates patents claimed against CareDx By Investing.com - Investing.com Australia

Feb 25, 2025
pulisher
Feb 25, 2025

CareDx Escapes $96 Million Verdict Over Natera DNA-Test Patents - Bloomberg Law

Feb 25, 2025

Caredx Inc Stock (CDNA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$142.51
price down icon 1.38%
diagnostics_research DGX
$168.82
price up icon 1.44%
diagnostics_research LH
$235.65
price down icon 0.50%
diagnostics_research WAT
$364.44
price down icon 2.33%
diagnostics_research MTD
$1,201.99
price down icon 1.15%
diagnostics_research IQV
$181.43
price down icon 2.15%
Cap:     |  Volume (24h):